Truist Financial Has Lowered Expectations for Leidos (NYSE:LDOS) Stock Price

Leidos (NYSE:LDOS) had its target price decreased by stock analysts at Truist Financial from $185.00 to $165.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the aerospace company’s stock. Truist Financial’s price objective indicates a potential upside of 26.43% from the company’s current price.

Several other brokerages also recently commented on LDOS. Cantor Fitzgerald started coverage on shares of Leidos in a research note on Friday, February 7th. They issued an “overweight” rating and a $185.00 target price for the company. Wells Fargo & Company lowered their target price on shares of Leidos from $199.00 to $197.00 and set an “overweight” rating for the company in a research note on Wednesday. The Goldman Sachs Group downgraded shares of Leidos from a “buy” rating to a “neutral” rating and lowered their target price for the company from $228.00 to $153.00 in a research note on Thursday, December 12th. Robert W. Baird upped their target price on shares of Leidos from $180.00 to $218.00 and gave the company an “outperform” rating in a research note on Wednesday, October 30th. Finally, Citigroup upped their target price on shares of Leidos from $194.00 to $220.00 and gave the company a “buy” rating in a research note on Wednesday, October 30th. Five investment analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $176.27.

Leidos Trading Down 4.6 %

LDOS opened at $130.50 on Wednesday. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.23 and a quick ratio of 1.15. The company has a market cap of $17.41 billion, a price-to-earnings ratio of 14.86, a price-to-earnings-growth ratio of 0.92 and a beta of 0.66. The firm has a 50 day simple moving average of $148.21 and a 200 day simple moving average of $157.48. Leidos has a fifty-two week low of $119.31 and a fifty-two week high of $202.90.

Leidos (NYSE:LDOS) last posted its quarterly earnings results on Tuesday, February 11th. The aerospace company reported $2.37 earnings per share for the quarter, topping analysts’ consensus estimates of $2.24 by $0.13. Leidos had a net margin of 7.37% and a return on equity of 30.31%. On average, sell-side analysts anticipate that Leidos will post 10.03 earnings per share for the current year.

Insider Buying and Selling

In other Leidos news, Director Noel B. Geer bought 2,000 shares of Leidos stock in a transaction that occurred on Wednesday, November 20th. The stock was acquired at an average price of $161.13 per share, for a total transaction of $322,260.00. Following the completion of the acquisition, the director now owns 2,000 shares of the company’s stock, valued at $322,260. This trade represents a ∞ increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.96% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in LDOS. Rakuten Securities Inc. lifted its stake in Leidos by 1,460.0% in the third quarter. Rakuten Securities Inc. now owns 156 shares of the aerospace company’s stock valued at $25,000 after acquiring an additional 146 shares during the last quarter. Duncker Streett & Co. Inc. acquired a new stake in Leidos in the fourth quarter valued at $27,000. Ashton Thomas Securities LLC acquired a new stake in Leidos in the third quarter valued at $29,000. Berbice Capital Management LLC acquired a new stake in Leidos in the fourth quarter valued at $29,000. Finally, Northwest Investment Counselors LLC acquired a new stake in Leidos in the third quarter valued at $30,000. Institutional investors and hedge funds own 76.12% of the company’s stock.

Leidos Company Profile

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.